Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 10, 2011, Pages 1214-1216

  Kamphuis, Lieke S ^a   Lam Tse, Wai Kwan ^a   Dik, Willem A ^a   Van Daele, Paul L ^a   Van Biezen, Paula ^a   Kwekkeboom, Dik J ^a   Kuijpers, Robert W ^a   Hooijkaas, Herbert ^a   Van Laar, Jan A ^a   Bastiaans, Jeroen ^b   Baarsma, G Seerp ^b   Van Hagen, P Martin ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 8; LYSOZYME; SOMATOSTATIN RECEPTOR;

AXILLARY LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG RESPONSE; DYSPNEA; FATIGUE; HUMAN; LETTER; LUNG SARCOIDOSIS; LYMPH NODE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS; SCINTIGRAPHY; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; THORACIC LYMPH NODE;

EID: 81455128768     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.184.10.1214     Document Type: Letter

References (12)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-2165.
2. Baughman RP, Iannuzzi M. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs 2003;17:425-431. (Pubitemid 37500758)
3. Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, et al. Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006;174:795-802. (Pubitemid 44511661)
4. Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W Jr, Sands BE. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006;23:201-208. (Pubitemid 47596315)
5. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vuk-Pavlovic Z, Schroeder DR. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 2003;124:177-185. (Pubitemid 36851350)
6. Sandborn WJ, Hanauer SB, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh DG, Panaccione R, Wolf D, Kent JD, Bittle B, et al. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut 2007;56:1232-1239. (Pubitemid 47300424)
7. Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, et al. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med 2007;146:829-838. (Pubitemid 351650483)
8. Bargagli E, Bianchi N, Margollicci M, Olivieri C, Luddi A, Coviello G, Grosso S, Rottolli P. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Scand J Clin Lab Invest 2008;68:479-483.
9. Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 2003;124:186-195. (Pubitemid 36851351)
10. Shigehara K, Shijubo N, Ohmichi M, Yamada G, Takahashi R, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S, et al. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000;162:1979-1982.
11. Kwekkeboom DJ, Krenning EP, Kho GS, Breeman WA, van Hagen PM. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 1998;25:1284-1292. (Pubitemid 28446055)
12. Duet M, Lioté F. Somatostatin and somatostatin analog scintigraphy: any benefits for rheumatology patients? Joint Bone Spine 2004;71:530-535. (Pubitemid 39626721)